Clair Health logo

Clair Health

Clair Health is in a16z speedrun SR006. Based in Mountain View, California, United States of America. Team of 7, founded in 2025.

  • Healthcare
  • Hardware

Facts

Location
Mountain View, California, United States of America
Team size
7
Founded
2025

About Clair Health

GPAgent's own fund-neutral profile, written from public information. Updated Sep 25, 2026.

Summary

Clair Health, founded in 2025 and based in Mountain View, California, is developing what it describes as the first wearable device capable of continuously monitoring female hormones — including estrogen, progesterone, LH, and PdG — without blood draws. The product takes the form of a jewelry-inspired wrist wearable that captures over 130 biomarkers through a multi-modal sensor array, which feeds into a proprietary female biology model to generate personalized hormonal insights. Those insights appear aimed at helping women navigate a range of health areas, including fertility planning, skin health, mood, athletic performance, and perimenopause. The company is a small team of seven and appears to be in the pre-shipment phase, with founding member devices expected to ship in late 2026.

Business model

Clair Health generates revenue through device sales and a recurring subscription for its pro app tier, combining a hardware purchase with software-driven insights. Pricing follows a consumer electronics model, with discounted early-access bundles for founding members and likely premium pricing at retail.

Go-to-market

Clair Health targets women across various life stages — from those tracking fertility to athletes to those navigating menopause — and has pursued both direct-to-consumer and business-to-business sales channels simultaneously. The D2C motion centers on a founding member program with limited early-access pricing, HSA/FSA eligibility, and community engagement, while B2B contracts have likely been signed with corporate wellness, healthcare, or research partners. Customer acquisition appears to lean on media coverage across more than 50 platforms and an early waitlist model to build demand ahead of the product's retail launch.

Founders (1)

  • Jenny Duan
    CEO

Score a cohort against your own thesis

GPAgent's sourcing agent reads cohorts like this one and scores each company against your fund's mandate in a private workspace. Your scores, notes, and pipeline never appear on these pages.

Join the waitlist